Hypertension, Resistant to Conventional Therapy Clinical Trial
Official title:
Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Homeopathy in Resistant Arterial Hypertension
Resistant hypertension (RHTN) is a common clinical problem faced by both primary care
clinicians and specialists worldwide. Patients with RHTN have higher rates of cardiovascular
events and mortality compared with patients with more easily controlled hypertension. In
addition, RHTN is often complicated by metabolic abnormalities.
Homeopathy, although widely used in hypertension, but no study has been taken to evaluate
the impact on resistant hypertension. The aim of this trial was to evaluate individualized
homeopathy on BP in patients with resistant hypertension.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02385864 -
CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension
|
N/A | |
Completed |
NCT01833429 -
Autonomic Dysfunction in Resistant Hypertension
|
N/A | |
Completed |
NCT02426099 -
Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension
|
Phase 4 | |
Recruiting |
NCT02623036 -
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
|
Phase 1 | |
Completed |
NCT02587533 -
Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation
|
N/A | |
Recruiting |
NCT01863082 -
Resistant Hypertension and Physical Activity Performed in a Heated Pool
|
N/A | |
Terminated |
NCT03730519 -
UK Registry for Baroreflex Activation Therapy
|
N/A | |
Active, not recruiting |
NCT05017935 -
RADIANCE Continued Access Protocol
|
N/A | |
Completed |
NCT01520506 -
Rapid Renal Sympathetic Denervation for Resistant Hypertension
|
N/A | |
Active, not recruiting |
NCT02369081 -
Optimum Treatment for Drug-Resistant Hypertension
|
Phase 4 | |
Withdrawn |
NCT04542681 -
MANP in African Americans With Hypertension
|
Phase 1 | |
Completed |
NCT05395403 -
Use of Automated Office Blood Pressure Monitoring
|
N/A | |
Recruiting |
NCT02057783 -
Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
|
N/A | |
Completed |
NCT01630928 -
Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors
|
N/A | |
Completed |
NCT01848275 -
Full Length Versus Proximal Renal Arteries Ablation
|
N/A | |
Completed |
NCT01062763 -
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
|
Phase 3 | |
Completed |
NCT01834118 -
Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
|
N/A | |
Active, not recruiting |
NCT01703780 -
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
|
N/A | |
Not yet recruiting |
NCT02042066 -
Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension
|
Phase 1 | |
Completed |
NCT02667912 -
Distal Renal Denervation
|
N/A |